MOB3B and renal carcinoma: Similarly, low expression of MOB3B has been associated with malignant melanoma [35], mantle cell lymphoma [35], poor outcome of renal cancer [36] and adverse clinicopathological factors in PCa [37], together suggesting a possible tumor suppressor role for MOB3B.